BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11975663)

  • 21. Fructosamine-6-phosphates are deglycated by phosphorylation to fructosamine-3,6-bisphosphates catalyzed by fructosamine-3-kinase (FN3K) and/or fructosamine-3-kinase-related-protein (FN3KRP).
    Szwergold BS
    Med Hypotheses; 2007; 68(1):37-45. PubMed ID: 16920277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A convenient HPLC assay for the determination of fructosamine-3-kinase activity in erythrocytes.
    Krause R; Oehme A; Wolf K; Henle T
    Anal Bioanal Chem; 2006 Dec; 386(7-8):2019-25. PubMed ID: 17072594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzymatic kinetics regarding reversible metabolism of CS-0777, a sphingosine 1-phosphate receptor modulator, via phosphorylation and dephosphorylation in humans.
    Inaba SI; Yamaguchi-Goto M; Tanaka-Takanaka K; Yonesu K; Sakurai H; Kubota K; Izumi T
    Xenobiotica; 2018 Mar; 48(3):258-268. PubMed ID: 28287856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-evaluation of the fructosamine reaction.
    Phillipou G; Seaborn CJ; Phillips PJ
    Clin Chem; 1988 Aug; 34(8):1561-4. PubMed ID: 3402055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple colorimetric assay for measuring fructosamine 3 kinase activity.
    Cikomola JC; Kishabongo AS; Vandepoele K; Mulder M; Katchunga PB; Laukens B; Schie LV; Grootaert H; Callewaert N; Speeckaert MM; Delanghe JR
    Clin Chem Lab Med; 2017 Jan; 55(1):154-159. PubMed ID: 27394048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Hypothesis: Fructosamine-3-Kinase-Related-Protein (FN3KRP) Catalyzes Deglycation of Maillard Intermediates Directly Downstream from Fructosamines.
    Szwergold B
    Rejuvenation Res; 2021 Aug; 24(4):310-318. PubMed ID: 34314247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue distribution and evolution of fructosamine 3-kinase and fructosamine 3-kinase-related protein.
    Delplanque J; Delpierre G; Opperdoes FR; Van Schaftingen E
    J Biol Chem; 2004 Nov; 279(45):46606-13. PubMed ID: 15331600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of enzymes acting on alpha-glycated amino acids in Bacillus subtilis.
    Wiame E; Duquenne A; Delpierre G; Van Schaftingen E
    FEBS Lett; 2004 Nov; 577(3):469-72. PubMed ID: 15556630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The estimation of serum fructosamine: an alternative measurement to glycated haemoglobin.
    Hindle EJ; Rostron GM; Gatt JA
    Ann Clin Biochem; 1985 Jan; 22 ( Pt 1)():84-9. PubMed ID: 3838635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
    Szwergold BS
    Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Many fructosamine 3-kinase homologues in bacteria are ribulosamine/erythrulosamine 3-kinases potentially involved in protein deglycation.
    Gemayel R; Fortpied J; Rzem R; Vertommen D; Veiga-da-Cunha M; Van Schaftingen E
    FEBS J; 2007 Sep; 274(17):4360-74. PubMed ID: 17681011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of acute hyperglycaemia on the serum fructosamine and blood glycated haemoglobin concentrations in canine samples.
    Marca MC; Loste A; Ramos JJ
    Vet Res Commun; 2000 Feb; 24(1):11-6. PubMed ID: 10703749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycated hemoglobin in fractionated erythrocytes.
    Nakashima K; Nishizaki O; Andoh Y; Takei H; Itai A; Yoshida Y
    Clin Chem; 1989 Jun; 35(6):958-62. PubMed ID: 2731368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substrate specificity engineering of Escherichia coli derived fructosamine 6-kinase.
    Kojima K; Mikami-Sakaguchi A; Kameya M; Miyamoto Y; Ferri S; Tsugawa W; Sode K
    Biotechnol Lett; 2013 Feb; 35(2):253-8. PubMed ID: 23076362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycated haemoglobin and fructosamine in non-diabetic subjects with chronic renal failure.
    Morgan LJ; Marenah CB; Morgan AG; Burden RP; John WG
    Nephrol Dial Transplant; 1990; 5(10):868-73. PubMed ID: 2128382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of albumin and detergent on the reduction of NBT by 1-deoxy-1-morpholinofructose.
    Podzorski E; Wells FE
    Ann Clin Biochem; 1989 Nov; 26 ( Pt 6)():496-9. PubMed ID: 2619229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
    GoĊ‚embiewska E
    Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term assessment of glucose control by haemoglobin-AGE measurement.
    Wolffenbuttel BH; Giordano D; Founds HW; Bucala R
    Lancet; 1996 Feb; 347(9000):513-5. PubMed ID: 8596270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycated haemoglobin and glycated protein and glucose concentrations in necropsy blood samples.
    John WG; Scott KW; Hawcroft DM
    J Clin Pathol; 1988 Apr; 41(4):415-8. PubMed ID: 3366927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure.
    Morgan L; Marenah CB; Jeffcoate WJ; Morgan AG
    Diabet Med; 1996 Jun; 13(6):514-9. PubMed ID: 8799653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.